Defining the Skin and Blood Biomarkers of Ichthyosis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-01-31

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Ichthyosis is a group of genetic skin disorders that present with dry, thickened, scaly, or flaky skin. As of today, there is no cure or treatment. Doctors can only treat the dry skin with different types of emollients to soften the scale. A deeper understanding of this disease is required to develop better treatments. There are different types of cells and cell-produced signals (biomarkers) that are being studied in order to help find these new treatments. Looking at biomarkers has been successful in helping us to understand other skin disorders better. The purpose of this study is to determine which blood and skin biomarkers characterize ichthyosis.

Hypothesis: We predict that the biomarkers correlating with disease activity in Netherton syndrome will be different than the biomarkers found to correlate with the lamellar and other ichthyosis phenotype.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

National Registry for Ichthyosis and Related Disorders

NCT00074685

Darier Disease Hailey-Hailey Disease Hyperkeratosis, Epidermolytic +4 more

COMPLETED

Study of Scaling Disorders and Other Inherited Skin Diseases

NCT00001292

Genetic Skin Disease Keratosis Follicularis Lamellar Ichthyosis

COMPLETED

The Efficacy and Safety of Secukinumab in Patients With Ichthyoses

NCT03041038

Ichthyosis Autosomal Recessive Congenital Ichthyosis Lamellar Ichthyosis +3 more

COMPLETED PHASE2

Epidermal Growth Factor Receptor Inhibition for Keratinopathies

NCT06545695

Epidermolytic Ichthyosis Palmoplantar Keratoderma Pachyonychia Congenita

NOT_YET_RECRUITING PHASE1/PHASE2

Evaluate the Evolution of Body and Scalp Skin Discomfort in Patients With Hereditary Ichthyosis After Wraps (EnvelopIchtyose)

NCT05979506

Ichthyosis Inherited

NOT_YET_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Objectives:

1. To define a panel of skin and blood biomarkers associated with disease activity and pruritus in Netherton syndrome, lamellar ichthyosis, and other ichthyosis subtypes.
2. To determine if blood samples can serve as surrogates for skin immune activation and will correlate with disease severity.
3. To determine FLG, SPINK5, TGM1, or other mutation via buccal/saliva samples in ichthyosis subjects
4. To determine differences in alterations of epidermal lipids and proteins in the outer stratum corneum of epidermis collected from tape strips in patients with ichthyosis compared to the general population. There will also be a difference detected in epidermal lipids from blood samples.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ichthyosis Netherton Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

Healthy subjects with no history of ichthyosis from 1 year to 60 years of age.

No interventions assigned to this group

Ichthyosis

Subjects with a diagnosis of Netherton syndrome or ichthyosis from 1 year to 60 years of age.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Control and ichthyosis subjects may be of either sex and must be between 1-60 years of age at the time of enrollment
* Ichthyosis subjects include individuals with a diagnosis Netherton syndrome, lamellar ichthyosis, or other ichthyosis subtypes
* Ichthyosis subjects should not have administered systemic immunosuppressant therapy in the month before the study
* Ichthyosis subjects should not use topical immunosuppressants in the week before the study
* Ichthyosis subjects should not have applied emollients to the planned biopsy sites within 12 hours before biopsy, but can be applied elsewhere
* Controls may have no inflammatory disease, atopy, or obvious xerosis (urticaria, food allergy, allergic rhinitis or conjunctivitis, asthma)
* Controls for skin sampling may have no observable abnormality in the sampled skin and, to further assure the normality of the "normal" skin edges, must not have evidence of inflammation or epidermal change in the lesion to be surgically removed
* Subjects and guardians of minors must sign the approved IRB consent form(s) prior to initiation of the study protocol

* Subjects whose main diagnosis is deemed unsafe by the study investigator for study participation